Middle-market private equity is moving into defense subcontracting and government-services niches at a pace unusual for a sector sponsors have long treated as specialist-only, as budget growth cascades from primes down to smaller suppliers [1]. Advisors describe deal flow accelerating even as broader mid-market volume stays muted, concentrated among funds already fluent in government contracting mechanics [1]. For generalist sponsors eyeing the sector for the first time, the opportunity is real, but the diligence, governance, and exit mechanics differ enough from a standard platform buy that a copy-paste industrial roll-up thesis is a mistake.
Defense mid-market M&A is acquisition activity targeting government-contracting or defense-adjacent companies typically valued well under the billion-dollar enterprise values that headline prime-contractor deals — concentrated instead among specialty manufacturers, cleared IT services firms, and tier-two and tier-three subcontractors.
Defense budgets are pulling middle-market PE into a sector it used to treat as niche.
Merit Investment Bank's Chris Abato and Leonid Capital Partners' James Parker describe defense as one of the few corners of the mid-market where deal activity is accelerating rather than stalling, even as broader sponsor-backed volume stays soft [1]. The mechanism is straightforward: budget growth at the federal level does not stay with the half-dozen primes that dominate headlines — it flows downstream, through subcontracts, purchase orders, and long-term supply agreements, into a long tail of smaller, often founder-owned suppliers [1].
That downstream flow is what has pulled specialist funds like Leonid Capital into a sector generalist sponsors avoided for years, deterred by security-clearance requirements, contract-concentration risk, and unfamiliar procurement cycles [1]. The advisors note that dealmakers who understand those mechanics are seeing proprietary flow that never reaches a banked process, because many owners in this tier have no experience with — or interest in — a broad auction [1].
The generalist hesitation is rational, not lazy. A sponsor underwriting a facilities-services or industrial-distribution platform can model demand with a spreadsheet and a customer list. A sponsor underwriting a cleared systems-integration shop has to underwrite the government's own procurement calendar, appropriations timing, and program-office relationships — variables that do not show up in a standard quality-of-earnings report and that most generalist deal teams have never had to price.
Consolidation is happening at the subcontractor tier, not the prime tier.
The fragmentation that makes defense subcontracting attractive to platform builders looks structurally similar to other services verticals PE has already consolidated. Alpine Investors' decision to launch its first UK platform investment, Eight Group Service Partners, in the fragmented facilities-management market is built on the same logic: a large base of small, owner-operated businesses serving a concentrated set of large customers, with no single competitor controlling more than a sliver of volume [2].
Apply that pattern to defense: a handful of primes procure from a long tail of specialty machining shops, cleared IT integrators, and niche testing labs, most of them too small individually to interest a strategic acquirer but collectively representative of a durable, budget-linked demand base. The buy-and-build math that worked in UK technical services — acquire scale, standardize back-office and compliance functions, bid larger contracts as a combined entity — maps closely onto defense subcontracting, with one added variable: security clearances and facility certifications do not transfer as cleanly as customer contracts do.
That non-transferability is the single biggest structural difference between a defense roll-up and every other fragmented-services thesis a mid-market fund has run. In facilities management, an acquired branch can be re-badged and integrated within a quarter. In defense subcontracting, a facility clearance held at the target level can take months to re-sponsor under new ownership, and personnel clearances attach to individuals, not to the entity that employs them. A platform strategy that assumes rapid integration on day one is underwriting a timeline the government's own security apparatus does not guarantee.
The structural-demand thesis mirrors what already reshaped healthcare.
Sponsors chasing durable, demographically or policy-driven demand growth are not new to defense — the same pattern has already reshaped healthcare investing. Montagu, Kohlberg, and Arlington Capital Partners are running a comparable playbook in medical textiles, where rising demand for wound care and reproductive-health products is pulling sponsor capital into niches once considered too small or too specialized for generalist buyers [3].
That specialization gets rewarded with mandate expansion and internal promotion once a thesis matures. Amulet Capital elevated healthcare dealmaker Sam Brinkley to partner after he joined the firm in 2020, was promoted to principal in 2024, and led its fertility and reproductive-health investments — a five-year arc from generalist hire to sector authority [4]. Defense-focused funds are on a similar trajectory: specialist shops that built deep procurement and clearance expertise years ago are now the ones best positioned to underwrite the subcontractor wave, while generalists without that fluency are effectively locked out of the best proprietary flow.
The parallel is instructive for how a generalist sponsor should staff a defense entry rather than a reason to avoid the sector. Amulet did not backfill its fertility thesis with a generalist associate and a stack of market research — it built sector fluency over years and then promoted from within once that fluency proved out in closed deals [4]. A fund entering defense subcontracting for the first time should expect a similar build cycle: a cleared or formerly cleared operating partner, a relationship network inside program offices, and a multi-year runway before proprietary deal flow outpaces what a bank-run process would surface anyway.
Governance risk changes when the government is the customer.
Sponsors that place designated directors on the boards of defense-adjacent portfolio companies inherit a layer of personal liability exposure that goes beyond a typical platform investment. Recent Delaware Chancery Court opinions have sharpened the risks facing both designated directors and the stockholders who appoint them, particularly where designee loyalty to the appointing sponsor conflicts with fiduciary duty to the company [5].
In a defense contractor, that conflict is compounded. Foreign ownership, control, or influence (FOCI) mitigation agreements, facility security clearances, and contract novation requirements all impose obligations on directors that have no equivalent in a standard industrial services platform. A designated director who would face only garden-variety Delaware exposure on a typical portfolio company board can face additional regulatory and clearance-related liability on a defense-facing one — a distinction sponsors negotiating designation rights should price in before signing, not after a Chancery Court opinion forces the issue [5].
The practical implication shows up in board composition itself. Some FOCI mitigation structures require independent, cleared directors with no ongoing financial relationship to the sponsor sitting alongside — or instead of — the sponsor's own designees, which changes the calculus of control a fund typically expects to retain over a platform company. A sponsor that negotiates standard designation rights without confirming whether the target's existing or anticipated FOCI posture requires that structure can find, post-close, that its board seats carry less operating control than the term sheet implied.
Platform leadership turnover carries outsized stakes in defense roll-ups.
CEO transitions are already a meaningful source of platform risk across the market: roughly 1 in 7 CEO succession cases in the Russell 3000 and S&P 500 were forced rather than voluntary in both 2024 and 2025 [6]. That base rate matters more in a defense roll-up than in most other verticals, because leadership continuity is often tied directly to contract continuity.
Program managers and facility security officers frequently hold personal clearances that are difficult and slow to transfer. A forced departure that would simply trigger a search process at an ordinary industrial platform can, at a defense subcontractor, jeopardize an active contract's compliance posture or delay a novation the acquirer is counting on to close a deal. Sponsors underwriting a roll-up in this space should model leadership-transition risk explicitly, not as a generic key-person clause but as a contract-continuity variable with its own probability and cost.
Worth noting: the forced-departure data spans the Russell 3000 and S&P 500, not private, sponsor-backed subcontractors specifically, so the 1-in-7 figure is a market-wide base rate, not a defense-sector statistic [6]. But there is no reason to assume the underlying pressures — board conflict, performance shortfalls, activist or sponsor intervention — are less common in a levered defense platform than in a public company; if anything, the added layer of clearance and compliance obligations gives a defense platform's board more grounds for a forced exit, not fewer.
The Four-C Screen: a diligence framework for defense-adjacent targets, illustrated.
Generalist industrial diligence checklists miss the variables that actually drive value and risk in defense subcontracting. A tighter, four-part screen surfaces the questions that matter before a term sheet:
- Contract exposure. What share of revenue sits on cost-plus versus fixed-price contracts, and how concentrated is that revenue across a small number of program lines?
- Clearance moat. Does the company hold facility security clearances or personnel clearances that are genuinely difficult for a new entrant to replicate, or is the barrier mostly relationship-based and therefore transferable to a competitor?
- Customer concentration. How dependent is the business on a single prime or agency, and what happens to backlog if that one relationship sours or the program is descoped?
- Compliance posture. Is the target current on DFARS, CMMC, or equivalent cybersecurity and supply-chain requirements, or does the buyer inherit a remediation project disguised as an add-on?
Consider a stylized, illustrative example of how the screen changes an outcome. A sponsor evaluates two precision-machining shops as potential add-ons to a defense-manufacturing platform. Target A carries a top-secret facility clearance held for over a decade, serves four separate program offices across two primes, and passed its last CMMC assessment without a corrective action plan — it screens well on all four Cs. Target B has no facility clearance of its own (it subcontracts through a cleared partner), derives 80 percent of revenue from a single prime's single program, and has an open remediation item on supply-chain cybersecurity controls.
On a standard industrial checklist, both targets might look similar: comparable revenue, comparable EBITDA margin, comparable growth rate tied to the same underlying budget line. The Four-C Screen separates them immediately. Target A is a defensible, budget-linked asset whose moat should command a premium and whose integration risk is genuinely low. Target B is a single-relationship pass-through business wearing a defense label — its growth is real but its downside, if the program is descoped or the cleared partner walks, is far steeper than the headline multiple suggests. A sponsor that prices both the same way is the sponsor most likely to overpay for the wrong one.
The objection generalist sponsors raise most often is that this level of specificity is exactly why defense should be left to specialist funds — that the sector's idiosyncrasies make it a poor fit for a platform strategy built around operational value creation rather than government-relations expertise. That objection has real force at the prime-contractor level, where program-office relationships and lobbying infrastructure genuinely take years to build. It has far less force at the subcontractor tier, where the value creation levers — pricing discipline, back-office consolidation, cross-selling capacity across a combined customer base — are largely the same levers that work in any fragmented services roll-up. The clearance and compliance layer is a diligence and structuring problem to be solved with the right advisors, not a reason the operating thesis itself is invalid.
Sourcing defense targets requires different channels than the standard auction process.
Most of the value in this cycle sits with owners who have never run a formal sale process and are not represented by a bank that markets to financial sponsors. That is consistent with what the podcast's advisors describe: proprietary flow in defense subcontracting tends to originate through relationships built inside the sector, not through broadly distributed teasers [1]. Sponsors without an existing network of cleared operators, former program managers, or defense-focused intermediaries are, in practice, competing only for the leftovers that do reach a banked auction.
Mapping that founder-owned, off-market universe — and reaching owners directly before a process starts — is the problem our sourcing engine exists to solve. For sponsors building a defense thesis for the first time, the sourcing gap is often the binding constraint, not capital availability or underwriting appetite. Related reading on that dynamic is available on proprietary sourcing versus auction dynamics and on approaching founder-led businesses directly.
The near-term signal worth tracking is not the headline budget number but the pace at which specialty subcontractors — not primes — start showing up in deal-flow conversations among generalist mid-market sponsors. That shift, more than any single appropriations bill, will mark whether this cycle broadens beyond the specialist funds that got there first.
FAQ: Defense spending and middle-market PE deals
Rising federal defense budgets are flowing downstream from prime contractors to a long tail of smaller subcontractors and specialty suppliers, and advisors report deal flow accelerating in this tier even as broader mid-market activity stays muted [1]. Specialist funds fluent in procurement and clearance mechanics have been positioned to capture that flow first.
Defense targets carry variables a standard roll-up does not, including facility and personnel security clearances, FOCI mitigation obligations, and contract novation requirements tied to specific government agencies [5]. Leadership continuity also matters more, since forced CEO or program-manager departures can jeopardize active contracts rather than simply trigger a routine search [6].
Recent Delaware Chancery Court opinions have highlighted personal liability exposure for designated directors and the stockholders who appoint them, and that exposure compounds when the company also carries clearance or FOCI obligations [5]. Some FOCI mitigation structures also require independent cleared directors, which can reduce the operating control a sponsor's own board seats provide.
A four-part screen covering contract exposure, clearance moat, customer concentration, and compliance posture surfaces the variables that drive value and risk in this tier before a term sheet is signed. Two targets with similar revenue and margin can differ sharply in downside risk depending on whether their clearance and customer base are genuinely defensible or a single-relationship pass-through.
Sources & further reading
- ACG Insights (Middle Market Growth), "Rocketing Defense Spending's Effect on Middle-Market M&A" — podcast with Merit Investment Bank's Chris Abato and Leonid Capital Partners' James Parker
- PE Hub, "Alpine aims to replicate US technical services success in fragmented UK market" — launch of Eight Group Service Partners
- PE Hub, "Montagu, Kohlberg, Arlington bet on medical textiles; Increased demand for fertility treatment drives Amulet's CV of US Fertility"
- PE Hub, "Amulet Capital promotes healthcare dealmaker Sam Brinkley to partner" — joined 2020, principal 2024, partner promotion
- Harvard Law School Forum on Corporate Governance, "The Risks of Designated Directorships—Current Guidance for Directors and Those Who Appoint Them"
- Harvard Law School Forum on Corporate Governance, "Forced CEO Departures" — roughly 1 in 7 CEO succession cases forced, 2024–2025